Dogwood Therapeutics, Inc. (DWTX)
NASDAQ: DWTX · Real-Time Price · USD
2.650
+0.330 (14.22%)
Aug 28, 2026, 4:00 PM EDT - Market closed
Dogwood Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 9.61 | 6.52 | 14.85 | 3.32 | 7.03 | 14.01 |
Cash & Short-Term Investments | 9.61 | 6.52 | 14.85 | 3.32 | 7.03 | 14.01 |
Cash Growth | -28.30% | -56.06% | 347.64% | -52.82% | -49.81% | -52.99% |
Prepaid Expenses | 0.43 | 0.75 | 0.83 | 0.71 | 1.18 | 1.35 |
Other Current Assets | 0.99 | 1.16 | 0.86 | 0.14 | 0.16 | 0.42 |
Total Current Assets | 11.03 | 8.43 | 16.54 | 4.17 | 8.37 | 15.78 |
Property, Plant & Equipment | 0.14 | 0.18 | 0.22 | - | - | - |
Goodwill | 11.96 | 12.4 | 11.81 | - | - | - |
Long-Term Deferred Charges | 57.35 | 69.14 | 65.71 | - | - | - |
Other Long-Term Assets | 0.02 | 0.02 | 0.02 | - | - | - |
Total Assets | 80.5 | 90.17 | 94.31 | 4.17 | 8.37 | 15.78 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 0.41 | 0.76 | 1.23 | 0.11 | 0.57 | 0.35 |
Accrued Expenses | 2.35 | 2.24 | 1.89 | 0.25 | 0.47 | 0.92 |
Current Portion of Leases | 0.06 | 0.06 | 0.05 | - | - | - |
Total Current Liabilities | 2.83 | 3.06 | 3.18 | 0.36 | 1.04 | 1.28 |
Long-Term Debt | - | - | 15.38 | - | - | - |
Long-Term Leases | 0.07 | 0.11 | 0.15 | - | - | - |
Long-Term Deferred Tax Liabilities | 9.2 | 12.11 | 11.31 | - | - | - |
Total Liabilities | 12.13 | 15.27 | 30.03 | 0.36 | 1.04 | 1.28 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 0 | 0 | 0 | 0 | 0 | 0 |
Additional Paid-In Capital | 196.25 | 183.86 | 67.86 | 65.58 | 63.5 | 58.43 |
Retained Earnings | -124.59 | -108.08 | -73.82 | -61.47 | -56.17 | -43.93 |
Treasury Stock | -0.3 | -0.3 | -0.3 | -0.3 | - | - |
Comprehensive Income & Other | -2.99 | -0.59 | -3.86 | - | - | - |
Total Common Equity | 68.37 | 74.9 | -10.12 | 3.81 | 7.33 | 14.5 |
Shareholders' Equity | 68.37 | 74.9 | 64.28 | 3.81 | 7.33 | 14.5 |
Total Liabilities & Equity | 80.5 | 90.17 | 94.31 | 4.17 | 8.37 | 15.78 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 0.13 | 0.16 | 15.59 | - | - | - |
Net Cash (Debt) | 9.48 | 6.36 | -0.74 | 3.32 | 7.03 | 14.01 |
Net Cash Growth | -28.25% | - | - | -52.82% | -49.81% | -52.99% |
Net Cash Per Share | 0.45 | 1.28 | -0.72 | 4.42 | 15.88 | 42.04 |
Filing Date Shares Outstanding | 33.99 | 33.4 | 1.91 | 0.77 | 0.73 | 0.33 |
Total Common Shares Outstanding | 33.63 | 29.74 | 1.33 | 0.77 | 0.73 | 0.33 |
Working Capital | 8.19 | 5.37 | 13.37 | 3.81 | 7.33 | 14.5 |
Book Value Per Share | 2.03 | 2.52 | -7.60 | 4.94 | 9.99 | 43.52 |
Tangible Book Value | 56.4 | 62.5 | -21.94 | 3.81 | 7.33 | 14.5 |
Tangible Book Value Per Share | 1.68 | 2.10 | -16.47 | 4.94 | 9.99 | 43.52 |
Machinery | 0.01 | 0.01 | 0.02 | - | - | - |